TY - JOUR
T1 - Immunofluorescence Labeling Indices in Myeloma and Related Monoclonal Gammopathies
AU - GREIPP, PHILIP R.
AU - WITZIG, THOMAS E.
AU - GONCHOROFF, NICK J.
AU - HABERMANN, THOMAS M.
AU - KATZMANN, JERRY A.
AU - O'FALLON, W. MICHAEL
AU - KYLE, ROBERT A.
N1 - Funding Information:
This study was supported in part by funds from the Mayo Foundation, the Harold and Harriet Toor Foundation, and the Edna I. Davis Estate.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1987
Y1 - 1987
N2 - We measured plasma cell labeling indices (LI) in 52 patients with monoclonal gammopathies. Cytoplasmic reactivity with polyspecific or κ- and λ-specific light chain anti-Ig reagents identified monoclonal plasma cells, plasmablasts, and lymphocytoid plasma cells. Among newly diagnosed untreated patients, a high immunofluorescence LI distinguished those with multiple myeloma (MM) from those with stable monoclonal gammopathies (P<0.002). Among treated patients with MM, those in the plateau phase of the disease had low LI, whereas patients in the relapse phase or early in treatment had high LI. The immunofluorescence LI correctly classified three more patients with newly diagnosed MM than did the tritiated thymidine LI technique. LI specific for the neoplastic plasma cells resulted in excellent discrimination of patients with active disease. Because results are easily and rapidly obtained, this technique is useful clinically.
AB - We measured plasma cell labeling indices (LI) in 52 patients with monoclonal gammopathies. Cytoplasmic reactivity with polyspecific or κ- and λ-specific light chain anti-Ig reagents identified monoclonal plasma cells, plasmablasts, and lymphocytoid plasma cells. Among newly diagnosed untreated patients, a high immunofluorescence LI distinguished those with multiple myeloma (MM) from those with stable monoclonal gammopathies (P<0.002). Among treated patients with MM, those in the plateau phase of the disease had low LI, whereas patients in the relapse phase or early in treatment had high LI. The immunofluorescence LI correctly classified three more patients with newly diagnosed MM than did the tritiated thymidine LI technique. LI specific for the neoplastic plasma cells resulted in excellent discrimination of patients with active disease. Because results are easily and rapidly obtained, this technique is useful clinically.
UR - http://www.scopus.com/inward/record.url?scp=0023607840&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023607840&partnerID=8YFLogxK
U2 - 10.1016/S0025-6196(12)65066-6
DO - 10.1016/S0025-6196(12)65066-6
M3 - Article
C2 - 3118117
AN - SCOPUS:0023607840
SN - 0025-6196
VL - 62
SP - 969
EP - 977
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 11
ER -